Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center. Obsessive-compulsive disorder: A 3-yr prospective follow-up study of individuals treated with serotonin reuptake inhibitors OCD follow-up study. J Psychiatr Res. 2006;40:502C10. [PubMed] [Google Scholar] 53. Olsen T, Mais AH, Bilet T, Martinsen EW. Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center. Nord J Psychiatry. 2008;62:39C45. [PubMed] [Google Scholar] 54. Whittal ML, Robichaud M, Thordarson DS, McLean PD. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: A 2-yr follow-up of two randomized tests. J Consult Clin Psychol. 2008;76:1003C14. [PubMed] [Google Scholar] 55. Reddy YC, Alur AM, Manjunath S, Kandavel T, Math SB. Long-term follow-up study of individuals with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30:267C72. [PubMed] [Google Scholar] 56. Braga DT, Manfro GG, Niederauer K, Cordioli AV. Full remission and relapse of obsessive-compulsive symptoms after cognitive-behavioral group therapy: A two-year follow-up. Braz J Psychiatr. 2010;32:164C8. [PubMed] [Google Scholar] 57. Cabedo E, Belloch Oxytetracycline (Terramycin) A, Carri C, Larsson C, Fernndez-Alvarez H, Garca F, et al. Group versus individual cognitive treatment for obsessive-compulsive disorder: Changes in severity at post-treatment and one-year follow-up. Behav Cogn Psychother. 2010;38:227C32. [PubMed] [Google Scholar] 58. Anholt GE, Aderka IM, vehicle Balkom AJ, Smit JH, Hermesh H, de Haan E, et al. The effect of major depression on the treatment of obsessive-compulsive disorder: Results from a 5-yr follow-up. J Affect Disord. 2011;135:201C7. [PubMed] [Google Scholar] 59. Anand N, Sudhir PM, Math SB, Thennarasu K, Janardhan Reddy YC. Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: A prospective 1-yr follow-up study. J Panic Disord. 2011;25:939C45. [PubMed] [Google Scholar] 60. Marcks BA, Weisberg RB, Dyck I, Keller MB. Longitudinal course of obsessive-compulsive disorder in individuals with panic disorders: A 15-yr prospective follow-up study. Compr Psychiatry. 2011;52:670C7. [PMC free article] [PubMed] [Google Scholar] 61. Jakubovski E, Diniz JB, Valerio C, Fossaluza V, Belotto-Silva C, Gorenstein C, et al. Clinical predictors of long-term end result in obsessive-compulsive disorder. Depress Panic. 2013;30:763C72. [PubMed] [Google Scholar] 62. Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, et al. Long-term end result in adults with obsessive-compulsive disorder. Depress Panic. 2013;30:716C22. [PMC free article] [PubMed] [Google Scholar] 63. Eisen JL, Sibrava NJ, Boisseau CL, Mancebo MC, Stout RL, Pinto A, et al. Five-year course of obsessive-compulsive disorder: Predictors of remission and relapse. J Clin Psychiatry. 2013;74:233C9. [PMC free article] [PubMed] [Google Scholar] 64. Cherian AV, Math SB, Kandavel T, Reddy YC. A 5-yr prospective follow-up study of individuals with obsessive-compulsive disorder treated with serotonin reuptake Rabbit Polyclonal to RNF111 inhibitors. J Affect Disord. 2014;152-154:387C94. [PubMed] [Google Scholar] 65. Cherian AV, Pandian D, Bada Math S, Kandavel T, Janardhan Reddy YC. Family accommodation of obsessional symptoms and naturalistic end result of obsessive-compulsive disorder. Psychiatry Res. 2014;215:372C8. [PubMed] [Google Scholar] 66. Moritz S. A review on quality of life and major depression in obsessive-compulsive Oxytetracycline (Terramycin) disorder. CNS Oxytetracycline (Terramycin) Spectr. 2008;13:16C22. [PubMed] [Google Scholar] 67. Foa EB, Simpson HB, Liebowitz MR, Capabilities MB, Rosenfield D, Cahill SP, et al. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. J Clin Psychiatry. 2013;74:464C9. [PMC free article] [PubMed] [Google Scholar] 68. Moritz S, Rufer M, Fricke S, Karow A, Morfeld M, Jelinek L, et al. Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiatry. 2005;46:453C9. [PubMed] [Google Oxytetracycline (Terramycin) Scholar] 69. Hertenstein E, Thiel N, Herbst N, Freyer T, Nissen C, Klz AK, et al. Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: A study with 12 months follow-up. Ann Gen Psychiatry. 2013;12:4. [PMC free article] [PubMed] [Google Scholar] 70. Eisen JL, Pinto A, Mancebo MC, Dyck IR, Orlando ME, Rasmussen SA, et al. A 2-yr prospective follow-up study of the course of obsessive-compulsive disorder. J Clin Psychiatry. 2010;71:1033C9. [PMC free article] [PubMed] [Google Scholar] 71. Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, et al. Long-term end result of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110:4C13. [PubMed] [Google Scholar] 72. Shetti CN, Reddy YC, Kandavel T, Kashyap K, Singisetti S, Hiremath AS, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry. 2005;66:1517C23. [PubMed] [Google Scholar] 73. Cherian AV, Narayanaswamy JC, Srinivasaraju R, Viswanath B, Math SB, Kandavel T, et al. Does insight have specific correlation with sign sizes in OCD? J.
Home » Calcium-Activated Potassium (KCa) Channels » Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center
Categories
- Antivirals
- AP-1
- Apelin Receptor
- APJ Receptor
- Apoptosis
- Apoptosis Inducers
- Apoptosis, Other
- APP Secretase
- Aromatic L-Amino Acid Decarboxylase
- Aryl Hydrocarbon Receptors
- ASIC3
- AT Receptors, Non-Selective
- AT1 Receptors
- AT2 Receptors
- Ataxia Telangiectasia and Rad3 Related Kinase
- Ataxia Telangiectasia Mutated Kinase
- ATM and ATR Kinases
- ATPase
- ATPases/GTPases
- ATR Kinase
- Atrial Natriuretic Peptide Receptors
- Aurora Kinase
- Autophagy
- Autotaxin
- AXOR12 Receptor
- c-Abl
- c-Fos
- c-IAP
- c-Raf
- C3
- Ca2+ Binding Protein Modulators
- Ca2+ Channels
- Ca2+ Ionophore
- Ca2+ Signaling
- Ca2+ Signaling Agents, General
- Ca2+-ATPase
- Ca2+Sensitive Protease Modulators
- Caged Compounds
- Calcineurin
- Calcitonin and Related Receptors
- Calcium (CaV) Channels
- Calcium Binding Protein Modulators
- Calcium Channels
- Calcium Channels, Other
- Calcium Ionophore
- Calcium-Activated Potassium (KCa) Channels
- Calcium-ATPase
- Calcium-Sensing Receptor
- Calcium-Sensitive Protease Modulators
- CaV Channels
Recent Posts
- At diagnosis, many patients are asymptomatic diagnosed at a routine check by an increase in cholestatic liver enzymes
- When transfected right into a product packaging cell line, vector plasmids enable synthesis of several copies from the viral genome, that are consequently packaged into viral particles from the structural protein (Figure 1)
- Muscle tissue weakness was within the bilateral lower limbs (manual muscle tissue test (MMT); best: remaining = 4:4)
- DCs from bone tissue marrow and other tissue were labelled with an allophycocyanin (APC)-conjugated antibody for Compact disc11c (clone HL3) as well as among the following: Compact disc40 (clone 3/23), Compact disc80 (clone 16C10A1), Compact disc86 (clone GL1), or MHC-II (clone 3/23)
- Informatically selected features encompassed known ETEC antigens like the A and B subunits of heat-labile toxin (LT-A, and LT-B),CFs, the EatA19 serine protease, the EtpA adhesin,37 as well as the metalloprotease YghJ46 furthermore to conserved and serotype specific parts of flagellin molecules represented in the task and vaccine strains
Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center
← Nonetheless, the authors suggest that patients with paraesophageal hernias are often labeled as asymptomatic or minimally symptomatic, because the hernia has been present for years in an older patient and the gradual alterations in eating and postprandial symptoms are attributed to aging The virus was pelleted by centrifugation at 110,000 rcf for 1 h and resuspended in 200 l 0 →